понедельник, 26 сентября 2016 г.

Drugmaker Pfizer decides not to break up business

Drugmaker Pfizer decides not to break up business


Pfizer will not split into two publicly traded companies, a decision that, at least for now, ends Wall Street speculation over the drugmaker's future. The company said Monday it believes it is best positioned to maximize shareholder value in its current form, but it reserves the right to split in the future if the situation changes.



from Biotech News